The strategy operates as a feedback loop: live imaging, tracking, or physiologic measurements provide current information, which is compared with the treatment plan. If the observed target or patient state changes, the system can guide an update to target location, target size, or treatment parameters. Defined safety limits constrain those changes, supporting controlled delivery rather than unrestricted adjustment.
Anatomical change concerns where a target is positioned or how its size appears, whereas physiologic change concerns measurable biological state or response. Real-time target adjustment can account for either type of change by using the corresponding live information to revise delivery. This distinction matters when a planned target no longer matches the patient’s current condition.
Safety limits turn feedback into a controlled clinical decision rather than an unlimited response to every measurement. They define the boundaries within which location, size, or treatment parameters may be changed while care continues. This is important because real-time information can reveal motion or response, yet adjustments must remain consistent with the defined conditions governing delivery.
First, clinicians establish a treatment plan and identify the target. During care, live imaging, tracking, or physiologic measurements are collected and interpreted for motion or response. When the information indicates a relevant change, delivery parameters or the target representation can be updated within safety limits. The intervention then continues using the revised plan.
Core inputs include a treatment plan together with live imaging, tracking data, or physiologic measurements. These sources provide the current information needed to recognize changes in target position, size, motion, or biological response. Combining them links observation to delivery, allowing the clinical team or control system to determine whether an adjustment remains within the permitted safety limits.
The approach is relevant to image-guided procedures, radiotherapy, and other precisely targeted interventions. It is particularly useful when tumors, organs, or biological signals may change during treatment, because those changes can affect alignment or delivery. Applying current measurements to the treatment plan helps maintain targeting when the patient’s anatomy or physiology does not remain constant.
By responding to target motion or treatment-related changes, real-time target adjustment may improve alignment between the planned and current target. It can potentially increase treatment accuracy, spare surrounding tissue, and help maintain effectiveness when anatomy or biological signals change. These outcomes depend on the quality of live information and on adjustments remaining within defined safety limits.